Pharmacists across Canada fill more than 600 million prescriptions every year, and though somewhat rare, medication incidents do occur. When COVID-19 hit, it put unprecedented pressure on the industry.
Having previously updated the risks specified on the product monograph for one type of Janus Kinase inhibitor, Health Canada now says it can't rule out similar risks for other types.